Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Profit From Share Buyback Boom With These ETFs
Article By:
Sweta Killa
Wednesday, March 7, 2018 1:35 AM EDT
2018 is expected to be the second-busiest year for buybacks since the bull market began in 2009 as U.S. companies are on track to return a record $1 trillion to their shareholders.
Don’t Expect Immediate Dividends From The Buyback ETF
Article By:
David Dierking
Saturday, July 8, 2017 5:45 PM EDT
At a high level, I don’t feel like stock buybacks are the beneficial event that they’re often made out to be. They may provide a modest bounce in the short-term, but over the long-term they haven’t proven to be a significant value-added proposition.
ETF Watchlist: Week Of July 3, 2017
Article By:
David Dierking
Sunday, July 2, 2017 3:46 AM EDT
Biotechs are fairly volatile on a short-term basis but still represent one of the better long-term growth plays. With a P/E ratio of 22, the Biotech ETF (IBB) isn’t unreasonably expensive and may yet have more room to run.